Visita à exposição permanente de Zhongguancun: estruturas de fio fino canalizam "bombas cerebrais", elétrodos flexíveis resolvem o problema de "desconexão" da interface cérebro-máquina

2026中关村论坛年会正在举行，重装亮相的中关村常设展，让前沿科创成果真正做到了眼可看、手可触。
2026 ZGC Forum Annual Meeting is taking place, with the newly unveiled ZGC Permanent Exhibition making cutting-edge technological achievements truly visible and tangible.
记者探馆发现，医疗健康展区成为全场焦点之一。
Journalists visiting the exhibition found that the medical health exhibition area became one of the highlights of the event.
往来观众围着展台驻足、提问、拍照，从脑血管病治疗神经介入器械到千通道脑机接口系统，一个个硬核创新成果，展现出我国医疗创新硬实力。
Visitors gathered around the booths, stopping to ask questions and take photos, from neuro-interventional devices for treating cerebrovascular diseases to the thousand-channel brain-machine interface system, showcasing China’s hard power in medical innovation.

医疗创新成果触手可及
Medical innovation** achievements**** at your fingertips**

在艾柯医疗器械（北京）股份有限公司的展示区，一款细如发丝却结构精巧的金属支架模型格外引人注目。
At the display area of Aiko Medical Devices (Beijing) Co., Ltd., a metal stent model as fine as a hair yet intricately designed stood out.
今年，这家创新医疗器械企业亮出了神经介入产品“全家福”，从出血性、缺血性卒中治疗到通路类产品一字排开，那些用比头发丝还细的材料制成的精密器械，在展灯照射下泛着细碎的金属微光。
This year, the innovative medical device company showcased a “family portrait” of neuro-interventional products, lined up from hemorrhagic and ischemic stroke treatments to access products, with precision instruments made from materials thinner than a hair, shimmering under the exhibition lights.

（艾柯医疗神经介入产品“全家福” 郭博昊/摄）
(Aiko Medical Neuro-interventional Products “Family Portrait” Guo Bohao/Photo)

展台中央，一个30厘米长、通体银白的流水线型网状模型引的不少观展人驻足。
In the center of the booth, a 30-centimeter long, fully silver streamlined mesh model attracted many attendees.
工作人员向记者指出，这是Lattice血流导向密网支架放大300倍后的样子，它的真身直径仅有2到5毫米。
Staff pointed out to reporters that this is the Lattice flow-directed mesh stent magnified 300 times, with a real diameter of only 2 to 5 millimeters.

为了让记者更直观地感受产品的真实尺寸和质地，工作人员从展台一侧取出一个透明的圆形环状管。
To give reporters a more intuitive sense of the product’s real size and texture, staff took out a transparent circular tubular ring from one side of the booth.
她轻轻转动管子，一圈圈缠绕着的、纤细到几乎要融进光线里的支架徐徐伸出。
She gently turned the tube, and a stent, coiled so finely it almost blended with the light, slowly extended.
“颅内动脉瘤就像脑血管壁上鼓出来的一个‘小气球’，壁薄得很，血液不停冲击，随时可能破裂，是藏在脑子里的‘不定时炸弹’，也是出血性脑卒中的主要元凶。”
“The intracranial aneurysm is like a ‘small balloon’ bulging from the wall of a blood vessel in the brain, with a very thin wall, constantly under the impact of blood, and can rupture at any time; it is a ‘time bomb’ hidden in the brain and the main culprit of hemorrhagic stroke,”
工作人员指着屏幕上的血管示意图，给记者拆解治疗逻辑，“传统治疗是想办法把这个‘小气球’堵上，操作难度大，还很容易损伤血管。
the staff pointed to a vascular diagram on the screen, explaining the treatment logic to the reporters, “Traditional treatment attempts to block this ‘small balloon,’ which is difficult to operate and can easily damage the blood vessels.
我们这个支架的核心思路不是‘堵’，是‘导流’。”
The core idea of our stent is not ‘blocking’ but ‘diverting.’”

记者接过展品仔细端详，那根纤细到几乎看不见的金属丝里，还藏着一串像糖葫芦般串起的自膨式机械球囊。
The reporter took the exhibit for a closer look; within the nearly invisible fine metal wire, there was a string of self-expanding mechanical balloons strung together like candied hawthorns.
抵达病灶位置后，球囊会像雨伞撑开一样，把支架稳稳撑开，形成和血管内径完美贴合的网状中空管。
Upon reaching the lesion site, the balloon will open like an umbrella, steadily expanding the stent to form a mesh hollow tube that perfectly fits the inner diameter of the blood vessel.
“这个支架的网眼特别密，就像一个精准的‘筛子’，能把冲进动脉瘤的血流挡回去，同时给正常血流留出畅通的通道。
“This stent’s mesh is particularly dense, like a precise ‘sieve,’ capable of blocking the blood flow rushing into the aneurysm while leaving a clear path for normal blood flow.
时间一长，没有了血流冲击，动脉瘤就会慢慢萎缩闭合，再也没有破裂的风险。”
Over time, without blood flow impact, the aneurysm will gradually shrink and close, eliminating the risk of rupture,” the staff introduced.

该工作人员指出，这款支架术后12个月动脉瘤成功闭塞率超91.4%，支架内狭窄率仅1.8%，远低于国际主流器械14.5%的水平。
The staff pointed out that this stent has a successful occlusion rate of over 91.4% for aneurysms after 12 months, with a narrowing rate of only 1.8%, far below the 14.5% level of mainstream international devices.

2026年，脑机接口首次被写入《政府工作报告》，并与未来能源、量子科技、具身智能、6G等一同被列入未来产业。
In 2026, brain-machine interfaces were first included in the “Government Work Report,” alongside future industries such as future energy, quantum technology, embodied intelligence, and 6G.
展会现场，北京智冉医疗带来的千通道侵入式柔性脑机接口系统。
At the exhibition site, Beijing Zhirun Medical presented a thousand-channel invasive flexible brain-machine interface system.

“这款系统最高支持千通道的神经元信号采集，最大的突破，就是用了我们自研的可拉伸柔性电极。”
“This system supports up to a thousand channels for neuron signal acquisition, with the biggest breakthrough being the use of our self-developed stretchable flexible electrodes,”
展台负责人对着围拢的观众讲解，此前业内同类产品一直有个绕不开的“老大难”——大脑在颅腔内会有轻微的生理晃动，硬电极很容易出现“掉线”问题，信号采集说断就断。
the booth manager explained to the gathered audience that similar products in the industry have always faced a major challenge - slight physiological motion of the brain within the cranial cavity makes hard electrodes prone to “disconnection,” leading to abrupt signal loss.
而这款柔性电极能跟着大脑的活动同步拉伸、无缝贴合，彻底破解了“掉线”难题，神经信号采集效率也实现了量级提升。
However, this flexible electrode can stretch along with the brain’s activity, seamlessly fitting, completely solving the “disconnection” problem and significantly boosting the efficiency of neural signal acquisition.

记者了解到，这套系统能实现长期、稳定、高效率的神经元细胞级别信号采集，配合企业自研的深度神经网络解码算法，能做到毫秒级实时解码，实现超高精度的纯脑控运动控制，可适配多种临床场景。
The reporter learned that this system enables long-term, stable, and high-efficiency neuron cell-level signal acquisition, and combined with the company’s self-developed deep neural network decoding algorithm, it can achieve millisecond-level real-time decoding, enabling ultra-high precision pure brain-controlled movement, adaptable to various clinical scenarios.
目前，这款产品已经进入临床阶段，核心应用就是帮那些因高位截瘫、渐冻症、脑中风落下肢体运动功能障碍的患者，重建身体功能，找回生活的主动权。
Currently, this product has entered the clinical stage, with its core application being to help patients with upper limb paralysis, amyotrophic lateral sclerosis, and stroke-related motor function impairment to rebuild bodily functions and regain control of their lives.

“简单说，就是让患者用意念就能操控假肢、轮椅、手机、电脑这些设备，不用再靠家人全程照料，能自己吃饭、打字、和外界正常交流。”
“In simple terms, it allows patients to control prosthetics, wheelchairs, phones, and computers with their thoughts, without relying on family members for constant care, enabling them to eat, type, and communicate normally with the outside world,”
智冉医疗创始人、CEO宋麒告诉记者，随着技术持续落地，未来脑机接口还能实现人机之间的高速信息传递，成为人机共融的纽带。
Zhirun Medical’s founder and CEO, Song Qi, told reporters that as technology continues to be implemented, brain-machine interfaces will enable high-speed information transmission between humans and machines, becoming a bond of integration between the two.

北京医疗器械创新领跑全国
Beijing** medical device**** innovation leads the nation**

展台上一个个可触可感的创新成果，背后是北京医药健康产业领跑全国的硬核实力。
Each tangible and perceptible innovative achievement at the booth reflects Beijing’s hard power leading the nation’s pharmaceutical and health industry.
记者从本届中关村论坛年会上了解到，截至目前，本市已累计获批国家创新医疗器械84个、手术机器人43个、人工智能医疗器械60个，数量均居全国第一。
The reporter learned from this year’s ZGC Forum that, to date, the city has cumulatively approved 84 national innovative medical devices, 43 surgical robots, and 60 artificial intelligence medical devices, ranking first in the nation in terms of quantity.

2025年，北京全年获批上市创新药6款、国家创新医疗器械10款，在细胞与基因治疗、脑机接口、人工智能医疗器械等前沿领域接连实现关键突破。
In 2025, Beijing approved 6 innovative drugs and 10 national innovative medical devices for market launch throughout the year, achieving key breakthroughs in cutting-edge fields such as cell and gene therapy, brain-machine interfaces, and artificial intelligence medical devices.
继2025年拿下全国首个干细胞治疗药物后，2026年初，全球病毒性肝炎领域首个单抗药物、我国首个慢性丁肝治疗药物——立贝韦塔单抗注射液在北京获批上市，一举攻克了慢性丁肝长期无高效靶向治疗药物的行业难题。
Following the approval of the nation’s first stem cell therapy drug in 2025, at the beginning of 2026, the world’s first monoclonal antibody drug in the field of viral hepatitis, and China’s first chronic hepatitis D treatment drug—Libevir beta monoclonal antibody injection—was approved for market launch in Beijing, successfully tackling the industry’s challenge of a lack of effective targeted treatments for chronic hepatitis D.
更让人惊喜的是，这款药从获批到在北京友谊医院开出全球首张国产原研处方，只用了约50天，跑出了创新药临床落地的“北京速度”。
Even more surprisingly, this drug took only about 50 days from approval to the issuance of the world’s first domestic original prescription at Beijing Friendship Hospital, demonstrating the “Beijing speed” for innovative drug clinical implementation.

市药监局药品注册处处长张亚冬表示，为了推动创新药从研发到上市提速增效，市药监局研究制定并印发创新药品项目制服务管理工作机制，累计纳入了300余个创新药品种专项服务，2025年推动23个品种成功纳入国家药监局优先审评与突破性治疗程序。
Zhang Yadong, director of the Drug Registration Department of the Municipal Drug Administration, stated that to accelerate and enhance the efficiency of innovative drugs from development to market, the Municipal Drug Administration has researched and established a service management work mechanism for innovative drug projects, incorporating more than 300 innovative drug varieties into specialized services, and in 2025, facilitated 23 varieties to successfully enter the National Medical Products Administration’s priority review and breakthrough therapy procedures.